Proline-Rich Motifs Control G2-CDK Target Phosphorylation and Priming an Anchoring Protein for Polo Kinase Localization.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
16 06 2020
Historique:
received: 26 11 2019
revised: 31 03 2020
accepted: 20 05 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 4 6 2021
Statut: ppublish

Résumé

The hydrophobic patch (hp), a docking pocket on cyclins of CDKs (cyclin-dependent kinases), has been thought to accommodate a single short linear motif (SLiM), the "RxL or Cy" docking motif. Here we show that hp can bind different motifs with high specificity. We identify a PxxPxF motif that is necessary for G2-cyclin Clb3 function in S. cerevisiae, and that mediates Clb3-Cdk1 phosphorylation of Ypr174c (proposed name: Cdc5 SPB anchor-Csa1) to regulate the localization of Polo kinase Cdc5. Similar motifs exist in other Clb3-Cdk1 targets. Our work completes the set of docking specificities for the four major cyclins: LP, RxL, PxxPxF, and LxF motifs for G1-, S-, G2-, and M-phase cyclins, respectively. Further, we show that variations in motifs can change their specificity for human cyclins. This diversity could provide complexity for the encoding of CDK thresholds to achieve ordered cell-cycle phosphorylation.

Identifiants

pubmed: 32553169
pii: S2211-1247(20)30737-3
doi: 10.1016/j.celrep.2020.107757
pmc: PMC7301157
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Saccharomyces cerevisiae Proteins 0
Proline 9DLQ4CIU6V
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107757

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Mol Biol Cell. 2005 Oct;16(10):5026-39
pubmed: 16093348
J Biol Chem. 2006 Aug 11;281(32):23167-79
pubmed: 16707497
Mol Cell. 2014 Jul 17;55(2):161-9
pubmed: 25038412
Yeast. 1998 Jul;14(10):953-61
pubmed: 9717241
NPJ Syst Biol Appl. 2017 Mar 6;3:7
pubmed: 28649434
J Biol Chem. 2005 Nov 11;280(45):37301-9
pubmed: 16135509
J Cell Biol. 2000 Feb 7;148(3):441-52
pubmed: 10662771
Mol Biol Cell. 1992 Jul;3(7):805-18
pubmed: 1387566
Am J Physiol Cell Physiol. 2011 Apr;300(4):C723-42
pubmed: 21209361
Biochemistry. 2002 Dec 31;41(52):15625-34
pubmed: 12501191
Nat Rev Mol Cell Biol. 2007 Feb;8(2):149-60
pubmed: 17245415
Nucleic Acids Res. 2009 Jun;37(11):e83
pubmed: 19443443
Yeast. 2004 Jul 15;21(9):793-800
pubmed: 15282802
Curr Biol. 2011 Oct 11;21(19):1615-23
pubmed: 21945277
Genetics. 2016 Dec;204(4):1479-1494
pubmed: 27794027
Mol Cell. 2016 Aug 18;63(4):686-695
pubmed: 27453045
Mol Biosyst. 2012 Jan;8(1):268-81
pubmed: 21909575
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Methods. 2001 Jul;24(3):218-29
pubmed: 11403571
Cell. 2016 Dec 15;167(7):1750-1761.e16
pubmed: 27984725
Mol Cell. 2019 Jul 11;75(1):76-89.e3
pubmed: 31101497
Nat Cell Biol. 1999 Nov;1(7):438-43
pubmed: 10559988
Nature. 2003 Oct 23;425(6960):859-64
pubmed: 14574415
Cell Cycle. 2007 Jun 1;6(11):1350-9
pubmed: 17495531
Yeast. 2004 Aug;21(11):947-62
pubmed: 15334558
Nat Struct Mol Biol. 2010 Sep;17(9):1051-7
pubmed: 20694007
Cell. 2003 Oct 3;115(1):83-95
pubmed: 14532005
Nat Struct Mol Biol. 2019 Jul;26(7):649-658
pubmed: 31270471
Annu Rev Biochem. 2018 Jun 20;87:921-964
pubmed: 29925267
Genes Dev. 2004 May 1;18(9):981-91
pubmed: 15105375
Mol Cell Biol. 2000 Aug;20(16):5858-64
pubmed: 10913169
Nat Struct Mol Biol. 2018 Dec;25(12):1093-1102
pubmed: 30455435
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Cell. 1993 May 7;73(3):499-511
pubmed: 8490963
Mol Cell. 1998 Aug;2(2):173-82
pubmed: 9734354
Nat Rev Mol Cell Biol. 2008 Sep;9(9):679-90
pubmed: 18698327
PLoS One. 2011 Apr 29;6(4):e19031
pubmed: 21559502
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W349-57
pubmed: 23748958
Genes Dev. 1992 Nov;6(11):2021-34
pubmed: 1427070
Curr Biol. 2015 Feb 2;25(3):316-325
pubmed: 25619768
Science. 2008 Oct 3;322(5898):104-10
pubmed: 18719252
J Mol Biol. 2002 Oct 25;323(3):573-84
pubmed: 12381310
J Biol Chem. 2012 Jan 13;287(3):1662-9
pubmed: 22117071
Nucleic Acids Res. 2017 Jul 3;45(W1):W464-W469
pubmed: 28387819
Cell Cycle. 2014;13(20):3260-70
pubmed: 25485506
Nature. 2005 Mar 3;434(7029):104-8
pubmed: 15744308
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15716-21
pubmed: 24019491
Mol Cell. 2019 May 16;74(4):758-770.e4
pubmed: 30982746
Mol Cell. 2011 Aug 5;43(3):406-17
pubmed: 21816347
Mol Cell Biol. 1996 Sep;16(9):4673-82
pubmed: 8756624
Mol Cell Biol. 2001 Aug;21(15):4868-74
pubmed: 11438644
Mol Biol Cell. 2017 Apr 15;28(8):1011-1020
pubmed: 28228549
J Biol Chem. 2001 Jan 19;276(3):1993-7
pubmed: 11067844
Nat Cell Biol. 2007 May;9(5):506-15
pubmed: 17417630
PLoS One. 2013;8(3):e57970
pubmed: 23520484
Proteins. 2010 Jul;78(9):2029-40
pubmed: 20455260
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8
pubmed: 9724724
Mol Cell. 2011 Jun 10;42(5):610-23
pubmed: 21658602
Trends Biochem Sci. 2018 May;43(5):380-394
pubmed: 29544874
Genes Dev. 1993 Jul;7(7A):1160-75
pubmed: 8319908
Dev Cell. 2004 Aug;7(2):263-74
pubmed: 15296722
Mol Cell Biol. 2000 Jan;20(1):286-98
pubmed: 10594031
Genes Dev. 2003 Jul 15;17(14):1789-802
pubmed: 12865300
Nature. 1996 Jul 25;382(6589):325-31
pubmed: 8684460

Auteurs

Mihkel Örd (M)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Kait Kaarel Puss (KK)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Rait Kivi (R)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Kaidi Möll (K)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Tuuliki Ojala (T)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Irina Borovko (I)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Ilona Faustova (I)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Rainis Venta (R)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Ervin Valk (E)

Institute of Technology, University of Tartu, Tartu 50411, Estonia.

Mardo Kõivomägi (M)

Department of Biology, Stanford University, Stanford, CA 94305, USA.

Mart Loog (M)

Institute of Technology, University of Tartu, Tartu 50411, Estonia. Electronic address: mart.loog@ut.ee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH